APOE ε4 is the most significant genetic risk factor for developing late-onset Alzheimer’s disease, and several studies investigated whether there was an interaction of APOE ε4 carriage with rosiglitazone or pioglitazone effects on cognition. The gene discussed is APOE; the disease is early-onset autosomal dominant Alzheimer disease.